This study revealed a novel mechanism of the regulation of aerobic glycolysis and proliferation in GBM cells through the ZCRB1/circHEATR5B/HEATR5B-881aa/JMJD5/PKM2 pathway, which can provide novel strategies and potential targets for GBM therapy [50]. The gene discussed is ZCRB1; the disease is glioblastoma.